The coronavirus pandemic has dominated the headlines and our daily lives for the past year. Medical News Today have covered this fast-moving, complex story with live updates on the latest news, interviews with experts, and an ongoing investigation into the deep racial disparities that COVID-19 has helped unmask.
However, this has not stopped us from publishing hundreds of fascinating stories on a myriad of other topics.
We begin this weeks Recovery Room with a survey of the latest multiple sclerosis (MS) research. There is currently no cure for this condition, but developments in immunotherapy, new drugs, and gut microbiome research give us hope.
We also hear from three women with endometriosis about their experience of living with the condition, often for many years before receiving a diagnosis. Its a revealing and sometimes frustrating read why is research into and the understanding of endometriosis so lacking?
There are also articles on caffeines effects during exercise, the link between consuming processed meat and dementia, why experiencing some stress may be beneficial, and why positive thinking may not always be the best strategy.
We highlight this research below, along with several other recent stories that you may have missed amid all the COVID-19 fervor.
Published as MS Awareness Month came to an end, this new Special Feature article looks at the latest research into the causes of and treatments for the condition.
MS affects around 2.8 million people worldwide. Its symptoms include fatigue, muscle weakness, dizziness, and vertigo, as well as problems with vision and memory.
The article looks at the history of MS and what remains unknown about its causes. It also covers new drug treatments and the emerging prospect of stem cell therapy, immunotherapy, and therapies designed to reverse the damage that MS causes to nerve cells. The gut microbiome may also play a role in the development of the condition.
To learn more about the latest MS research, click below.
Learn more here.
March was also Endometriosis Awareness Month, and MNT spoke to three women living with this condition to hear about their experience of diagnosis and how the condition has since affected their lives.
Endometriosis can affect so many parts of the body that doctors may misdiagnose it as a different chronic condition. As a result, many women live for years without a diagnosis that would guide treatment and proper management of the condition.
Given how debilitating the symptoms can be, receiving a late diagnosis can have enormous consequences on ones career, quality of life, and personal relationships.
Click below for some detailed insights into the day-to-day reality of living with endometriosis.
Learn more here.
According to the new research that MNT covered this week, drinking a cup of strong coffee 30 minutes before aerobic exercise may help a person burn more fat.
Existing research indicated that consuming caffeine improved performance during exercise, but the evidence for it promoting fat oxidation was scant. However, this new triple-blind, placebo-controlled study supports the theory that caffeine does help the body burn fat during exercise.
The article looks at the studys limitations, including the small number of participants and lack of information about their ethnicity, and the risks and side effects associated with caffeine overconsumption.
With over 94,000 page views in just 2 days, it quickly emerged as this weeks most popular news article.
Learn more here.
Another highly popular article, with over 92,000 page views in its first day, is our detailed look at the difference between triglyceride and cholesterol levels.
Both are important markers for a persons health, but they perform different roles in the body.
Triglycerides are the most abundant type of fat in the body and store excess energy, while cholesterol is a lipoprotein involved in hormone production, digestion, and vitamin D production. Cholesterol is produced in the liver but also occurs in many foods.
The article looks at the healthy ranges for triglyceride and cholesterol levels and provides advice on how to lower triglyceride and cholesterol levels, including some dietary and lifestyle changes to try.
Learn more here.
Eating one rasher of bacon per day may lead to a 44% higher risk of dementia and a 52% increase in the risk of Alzheimers disease. Eating unprocessed meat may be associated with reduced risks. These were two findings of a new observational study that MNT covered this week.
However, there are limitations to this kind of analysis, and one doctor who was not involved in the study says, [T]he data wouldnt persuade me to give up my breakfast bacon.
Learn more here.
Stress may not be all bad, after all. A new study suggests that people who do not report experiencing any stress score worse on cognition tests. They are also less likely to experience positive events and to give and receive emotional support. This indicates that stress may simply be part of living ones life.
Chronic stress can result in symptoms such as headaches, irritability, and insomnia, and it can also increase the risk of chronic health problems, such as depression and heart disease.
However, this finding in relation to cognitive health suggests that the relationship between stress and well-being may be more nuanced than most people tend to believe.
Learn more here.
Microplastic pollution in wastewater plants contributes to the spread of antibiotic resistant bacteria, according to a new study that MNT covered this week.
The direct impact of ingesting microplastics on human health is of growing concern. Most seafood samples contain traces of microplastics, and the particles may also contaminate bottled water.
This new study suggests that the threat goes even deeper. Microplastics appear to provide a habitat in which bacteria are able to swap DNA and take up antibiotic resistance genes more readily. This has implications for wastewater treatment and highlights the importance of reducing microplastics in the environment.
Learn more here.
A preliminary clinical trial of a genetically engineered protein resulted in a significant improvement in standard memory test scores among people with Alzheimers disease.
This idea has its origins in an observation that people with rheumatoid arthritis are 4050% less likely to develop Alzheimers disease and that a protein called granulocyte-macrophage colony-stimulating factor appears to offer some protection.
The scientists designed the new trial as a safety test, so they did not assess other cognitive improvements. However, after this early success, the team has started a trial of longer duration involving more participants.
Learn more here.
In this article, our team looked at the evidence for various foods encouraging a person to reach their full potential height.
They assessed eggs, dairy, almonds, beans, fish, fruits, and sweet potatoes. However, once a person reaches the end of puberty, it is no longer possible for their bones to lengthen, and they will stop growing taller.
This highlights the importance of good nutrition throughout childhood and early adulthood. After that time, no food will bring on a further growth spurt. However, there are foods that can help maintain good bone health throughout a persons life.
Learn more here.
Can positive thinking go too far? Is it always appropriate to tell someone that everything happens for a reason? Could demanding positivity, even in the most tragic circumstances, have negative consequences? These are some of the questions that this new article addresses.
To read more about why allowing oneself to feel negative emotions and to talk about them, without forced positivity, can often be constructive, click below.
Learn more here.
We hope that this weeks Recovery Room has provided a taste of the stories that we cover atMNT. We will be back with a new selection next week.
We publish hundreds of new stories and features every month. Here are some upcoming articles that may pique our readers interest:
- FDA Responds to Creative Medical Technology Holdings Regarding Its ImmCelz IND for Stroke Treatment - KPVI News 6 - May 14th, 2021
- Duluth health center specializes in regenerative medicine, hormone replacement therapy - Duluth News Tribune - May 14th, 2021
- Dr. Krger on Toxicities Associated With Allogeneic Stem Cell Transplant in Myeloma - OncLive - May 14th, 2021
- Magenta Therapeutics Announces Positive Preliminary Results from Phase 2 Clinical Trial of MGTA-145 in Multiple Myeloma and Provides an Update on its... - May 14th, 2021
- Genenta Phase I/II Glioblastoma Data at ASGCT Show Temferon Delivered Tumor-Focused Interferon ExpressionData presented at the 2021 American Society... - May 14th, 2021
- ViaCyte To Participate In World Medical Innovation Forum Panel On Future Of Cell Therapy For Type 1 Diabetes - PRNewswire - May 14th, 2021
- Omeros' Narsoplimab Pivotal Trial Data to Be Shared as an Oral Presentation at the European Hematology Association Congress - Business Wire - May 14th, 2021
- Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in May - Business Wire - May 14th, 2021
- Outlook for multiple myeloma: Figures and factors that affect it - Medical News Today - May 14th, 2021
- Global Regenerative Medicine for Cartilage Market Report 2021: Companies are Continuously Focusing on Introducing New Technologies to Survive in the... - May 14th, 2021
- UB celebrates 175th anniversary of its origins in study of medicine - UB Now: News and views for UB faculty and staff - University at Buffalo Reporter - May 14th, 2021
- Stem cell therapy for COVID-19 and ARDS - News-Medical.Net - May 7th, 2021
- Experimental COVID-19 lung treatment being tested at Ontario hospitals - CityNews Toronto - May 7th, 2021
- EP. 4: Optimizing Patient Selection for CAR T-Cell Therapy - OncLive - May 7th, 2021
- Could stem cells improve the outcome of ARDS in severe COVID-19? - News-Medical.Net - May 7th, 2021
- Motixafortide Reaches Primary End Point of Improved Stem Cell Mobilization in Multiple Myeloma Trial - Cancer Network - May 7th, 2021
- Restricting the Growth and Spread of Head and Neck Cancers - Technology Networks - May 7th, 2021
- The global stem cell therapy market is projected to reach USD 401 million by 2026 from - GlobeNewswire - May 7th, 2021
- UCLA team discovers how to restrict growth, spread of head and neck cancers | UCLA - UCLA Newsroom - May 7th, 2021
- NUS scientists found a key element that affects how genes are expressed in blood stem cells - Newswise - May 7th, 2021
- Citius Pharmaceuticals to Present Mino-Lok and COVID-related Respiratory Treatment Update at Benzinga Global Small Cap Conference on Thursday, May 13... - May 7th, 2021
- Mesoblast says its stem cell treatment saved lives of severely ill COVID patients - Stockhead - May 2nd, 2021
- Antiviral T cells safe, effective as off-the-shelf therapy for painful complication after stem cell transplants - News-Medical.Net - May 2nd, 2021
- Antiviral T cells protected, viable as off-the-shelf treatment for painful complication stem cells - Microbioz India - May 2nd, 2021
- Desperate family of boy, 9, with leukaemia have 10 days to save his life... - The Sun - May 2nd, 2021
- Orchard Therapeutics Announces Multiple Presentations at the 24th Annual Meeting of the American Society of Gene & Cell Therapy - GlobeNewswire - May 2nd, 2021
- Investigating CAR T-Cell Therapy for Use in Different Disease Types - Targeted Oncology - May 2nd, 2021
- Enhanced inhibition of tumor growth using TRAIL-overexpressing adipose-derived stem cells in combination with the chemotherapeutic agent CPT-11 in... - May 2nd, 2021
- Thomas Smeenk on Hemostemix's autologous stem cell therapy technology and why some call it 'the fountain of youth' - InvestorIntel - April 28th, 2021
- Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancer... - April 28th, 2021
- Fate Therapeutics Announces Four Presentations at the 2021 ASGCT Annual Meeting - GlobeNewswire - April 28th, 2021
- Therapeutic Solutions International Reports Regression of Established Tumors by Combining its Cancer Blood Vessel Targeting Immunotherapy with Low... - April 28th, 2021
- A review of baculovirus vectors in gene therapy | BTT - Dove Medical Press - April 28th, 2021
- Stem Cell Therapy for COPD: Hope and Exploitation - DocWire News - April 26th, 2021
- Axion BioSystems Announces Formation of Scientific Advisory Board - Business Wire - April 26th, 2021
- Global Cell Therapy Market By Therapy Type, By Therapeutic Area, By End User, By Cell Type, By Regional Outlook, Industry Analysis Report and... - April 24th, 2021
- Pure Red Cell Aplasia following ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation: Resolution with Daratumumab Treatment - DocWire... - April 24th, 2021
- Advancing the Development of Safe and Effective Regenerative Medicine Products | FDA - FDA.gov - April 24th, 2021
- New method helps map the specialized diversity and spatial location of cells within a tissue or tumor - News-Medical.Net - April 24th, 2021
- Chimeric embryo may have medical implications The Campus - The Campus - April 24th, 2021
- Survival and treatment patterns of patients with relapsed or refractory multiple myeloma in France - a cohort study using the French National... - April 24th, 2021
- Guenther Koehne, MD, Highlights Recent Advancements in the Treatment of Blood Cancers - Oncology Learning Network - April 24th, 2021
- Rinri Therapeutics raises 10 million to advance stem cell therapy for hearing loss - The Star - April 24th, 2021
- Cancer Diagnosis in Patient Given LentiGlobin Revised to Severe Anemia - Sickle Cell Anemia News - April 24th, 2021
- Hodgkin lymphoma: Symptoms, outlook, treatment, and more - Medical News Today - April 24th, 2021
- Tissue Repair, Mitochondrial Function and Wound Healing Explored in 2021 APS Presidents Symposium - Newswise - April 24th, 2021
- Axion BioSystems Announces Formation of Scientific Advisory Board - BioSpace - April 20th, 2021
- Avalon GloboCare is seeking to tap the power of cells to fight cancer and coronavirus - Proactive Investors USA - April 20th, 2021
- Rinri Therapeutics Raises 10 million from Existing Investors and UK Future Fund to Advance its Novel Stem Cell Therapy to Restore Hearing Loss -... - April 20th, 2021
- Global Regenerative Medicines Market 2020-2030: Opportunities in Drug Approvals and Strong Pipeline of Cell and Gene Therapies & Multiple... - April 20th, 2021
- FDA Grants Orphan Drug Status to Novel IRAK4 Inhibitor in AML and MDS - Targeted Oncology - April 20th, 2021
- Vertex Drops $900 Million to Expand Partnership with CRISPR Therapeutics - BioSpace - April 20th, 2021
- Kaleido Biosciences Announces Collaboration with Robert Jenq, MD, to Explore Potential of its Microbiome Metabolic Therapies (MMT) in Preventing... - April 20th, 2021
- Partner Content | Being bionic: the future of regenerative medicine - TheSpec.com - April 14th, 2021
- Ohio State Recruits Top Oncologist to Expand Cell Therapy Program, Lead Bone Marrow Transplant Services - Wexner Medical Center - The Ohio State... - April 14th, 2021
- Leukemia Cutis: Symptoms and Treatment - Healthline - April 14th, 2021
- Green: Variants and outbreaks continue to put stress on hospitals - Vermont Biz - April 14th, 2021
- CRISPR Therapies Pipeline Insights 2021: Analysis of Key Companies, Emerging Therapies, Recent Happenings and Futuristic Trends - GlobeNewswire - April 14th, 2021
- Consortium to investigate role of neurofilament light chain in neurodegenerative diseases Washington University School of Medicine in St. Louis -... - April 14th, 2021
- Man's heart healed by stem cell therapy and love of an old flame - Leeds Live - April 12th, 2021
- New pediatric cancer treatment method being used in Iran - Tehran Times - April 12th, 2021
- Personalized Cancer Vaccine Shows Early Efficacy in Patients With Diverse Tumor Types - Technology Networks - April 12th, 2021
- 1000th Stem Cell Transplant Given to Girl Who Is One in a Million - Stanford Children's Health Blog - Stanford Children's Health - April 10th, 2021
- Home : Stem Cell Treatments - April 10th, 2021
- Researchers discover unique regenerative property of cells in the early human embryo - News-Medical.net - April 10th, 2021
- Study reveals sex-differences in aging of the brain stem cell niche - News-Medical.net - April 10th, 2021
- Antibiotics need further study in cancer treatments - Chicago Daily Herald - April 10th, 2021
- Prolonged infection and inflammation drain immune responses as we age - Baylor College of Medicine News - April 10th, 2021
- Toward a transformative therapy for sickle cell patients - News-Medical.Net - April 10th, 2021
- Mass. Residents 55+ Or With 1 Medical Condition Can Now Get COVID Vaccine | WBZ NewsRadio 1030 - iHeartRadio - April 6th, 2021
- Mortality from Multiple Myeloma Within One Year Following Autologous Stem Cell Transplantation: Defining an Ultra-high Risk Population - DocWire News - April 6th, 2021
- BioRestorative Therapies Announces Appointment of Nickolay V. Kukekov, Ph.D to its Board of Directors - BioSpace - April 6th, 2021
- LGL Leukemia: Overview, Symptoms, and Treatment - Healthline - April 3rd, 2021
- Novel T-Cell Therapy MT-401 Under Evaluation in Post-Transplant AML - OncLive - April 3rd, 2021
- Funding the Next Generation of Cancer Therapies - Genetic Engineering & Biotechnology News - April 3rd, 2021
- Do Therapies for Alzheimer's & Parkinson's that Clear Abnormal Brain Proteins Make the Diseases Worse? - BioSpace - April 3rd, 2021
- Allogeneic hematopoietic stem cell transplantation for therapy-related myeloid neoplasms following treatment of a lymphoid malignancy - DocWire News - April 1st, 2021
- Insulin 100: How the road to a diabetes cure is yielding better treatments - News@UofT - April 1st, 2021
- The Government's Watchful Eye on Fraud Stemming from Stem Cell Therapy - Lexology - April 1st, 2021
- Introducing a neuro regenerative gene into mice with spinal cord injury improves motor function - News-Medical.net - April 1st, 2021